JINHAI MED TECH (02225) announced that the group expects to record an after-tax loss of approximately S$10.8 million for the year ending June 30, 2025, compared to an after-tax loss of approximately S$6 million for the year ended June 30, 2024. The increased net loss for the first half of 2025 is primarily attributed to a decrease in the group's gross profit of approximately S$5 million, resulting from reduced operational revenue from the group's minimally invasive surgical solutions and medical products and related services, as well as dormitory services businesses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments